Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
F. Nilüfer Yalçındağ, Sirel Gür Güngör, Mehmet Fatih Kağan Değirmenci, Almila Sarıgül Sezenöz, Zeynep Birsin Özçakar, Esra Baskın, Fatma Fatoş Yalçınkaya & Huban Atilla. (2021) The Clinical Characteristics of Pediatric Non-Infectious Uveitis in Two Tertiary Referral Centers in Turkey. Ocular Immunology and Inflammation 29:2, pages 282-289.
Read now
Read now
Cillin Condon, David O’Regan, Emma MacDermott & Orla Killeen. (2017) Self-management needs of children with JIA in Ireland: a qualitative survey of families. European Journal of Physiotherapy 19:4, pages 237-242.
Read now
Read now
Boris Hügle & Gerd Horneff. (2016) The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis. Expert Opinion on Pharmacotherapy 17:5, pages 703-714.
Read now
Read now
Cillin Condon, Marie Morgan, Susan Ward, Emma MacDermott & Orla Killeen. (2016) Physical activity levels of children with juvenile idiopathic arthritis. European Journal of Physiotherapy 18:1, pages 58-62.
Read now
Read now
Maja Bulatović Ćalasan & Nico M Wulffraat. (2014) Methotrexate in juvenile idiopathic arthritis: towards tailor-made treatment. Expert Review of Clinical Immunology 10:7, pages 843-854.
Read now
Read now
Lukas Bossaller & Achim Rothe. (2013) Monoclonal antibody treatments for rheumatoid arthritis. Expert Opinion on Biological Therapy 13:9, pages 1257-1272.
Read now
Read now
Articles from other publishers (41)
L Nijhuis, J F Swart, B J Prakken, J van Loosdregt & S J Vastert. (2023) The clinical and experimental treatment of Juvenile Idiopathic Arthritis. Clinical and Experimental Immunology.
Crossref
Crossref
Dilek YILDIZ. (2023) Juvenil İdiyopatik Artritte Hemşirelik Tanıları ve Bakım YaklaşımlarıNursing Diagnosis and Care Approaches In Juvenile Idiopathic Arthritis. Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi 6:1, pages 226-237.
Crossref
Crossref
Yonatan Butbul Aviel, Ariel Keinan, Michaela F. Hartmann, Stefan A. Wudy & Dov Tiosano. (2023) The effect of etanercept therapy on adrenal steroid metabolism in juvenile idiopathic arthritis: a steroid metabolomics approach. Pediatric Rheumatology 21:1.
Crossref
Crossref
Johanna R. Mora, Robert Wong, Mehmooda Shaikh & Margarita Askelson. (2021)
Analysis of the Immunogenicity from
Abatacept‐Treated
Pediatric Patients With
Polyarticular‐Course
Juvenile Idiopathic Arthritis: Findings From Two Phase
III
Clinical Trials
. ACR Open Rheumatology 4:2, pages 177-186.
Crossref
Crossref
Alexandria L. Chaulk, Chase Miller, Matthew Barke, Baruch Goldberg & Alla Goldberg. (2022) Systemic Immunosuppression for the Treatment of Pediatric Uveitis. International Ophthalmology Clinics 62:1, pages 155-175.
Crossref
Crossref
Mehul P. Jariwala & Sujata Sawhney. 2022. Handbook of Biologics for Rheumatological Disorders. Handbook of Biologics for Rheumatological Disorders
165
178
.
Jaqueline Cristina da Silveira Xavier e Castro, Stephanie Ferreira Botelho, Maria Auxiliadora Parreiras Martins, Liliana Batista Vieira & Adriano Max Moreira Reis. (2021) New drugs registered in Brazil from 2003 to 2013: analysis from the perspective of child health. Brazilian Journal of Pharmaceutical Sciences 57.
Crossref
Crossref
Monique Munro, Ann-Marie Lobo & Pooja Bhat. (2020) Pediatric Noninfectious Uveitis Medical Treatment Update. Advances in Ophthalmology and Optometry 5, pages 331-344.
Crossref
Crossref
Da-Wei Liu, Jiao-Jiao Chen, Xue-Mei Tang, Yu Zhang & Juan Zhou. (2019) Infliximab therapy and outcomes in patients with polyarticular juvenile idiopathic arthritis: a single-center study in China. World Journal of Pediatrics 16:1, pages 68-73.
Crossref
Crossref
Klaus-Michael Keller. 2020. Chronisch-entzündliche Darmerkrankungen. Chronisch-entzündliche Darmerkrankungen
393
425
.
A. A. KoniushevskaN. V. VaizerD. V. PasternakN. V. SydorenkoI. D. Taran. (2019) CLINICAL FEATURES OF JUVENILE IDIOРATHIC ARTHRITIS ONSET AND COURSE IN THE CONDITIONS OF ENVIRONMENTALLY UNFAVORABLE DONETSK REGION. World of Medicine and Biology 15:68, pages 070.
Crossref
Crossref
Daniela Impellizzeri, Rosalba Siracusa, Marika Cordaro, Alessio Filippo Peritore, Enrico Gugliandolo, Giuseppe Mancuso, Angelina Midiri, Rosanna Di Paola & Salvatore Cuzzocrea. (2018) Therapeutic potential of dinitrobenzene sulfonic acid (DNBS)-induced colitis in mice by targeting IL-1β and IL-18. Biochemical Pharmacology 155, pages 150-161.
Crossref
Crossref
Dan Turner, Frank M. Ruemmele, Esther Orlanski-Meyer, Anne M. Griffiths, Javier Martin de Carpi, Jiri Bronsky, Gabor Veres, Marina Aloi, Caterina Strisciuglio, Christian P. Braegger, Amit Assa, Claudio Romano, Séamus Hussey, Michael Stanton, Mikko Pakarinen, Lissy de Ridder, Konstantinos Katsanos, Nick Croft, Victor Navas-López, David C. Wilson, Sally Lawrence & Richard K. Russell. (2018) Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care—An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. Journal of Pediatric Gastroenterology & Nutrition 67:2, pages 257-291.
Crossref
Crossref
Rebecca A. Flaherty, Deborah L. Donahue, Katelyn E. Carothers, Jessica N. Ross, Victoria A. Ploplis, Francis J. Castellino & Shaun W. Lee. (2018) Neutralization of Streptolysin S-Dependent and Independent Inflammatory Cytokine IL-1β Activity Reduces Pathology During Early Group A Streptococcal Skin Infection. Frontiers in Cellular and Infection Microbiology 8.
Crossref
Crossref
Jens Klotsche, Kirsten Minden, Martina Niewerth & Gerd Horneff. (2018) Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA. Annals of the Rheumatic Diseases 77:7, pages 996-1002.
Crossref
Crossref
Jorg van Loosdregt, Femke van Wijk, Berent Prakken & Bas Vastert. (2017) Update on research and clinical translation on specific clinical areas from biology to bedside: Unpacking the mysteries of juvenile idiopathic arthritis pathogenesis. Best Practice & Research Clinical Rheumatology 31:4, pages 460-475.
Crossref
Crossref
Elena E. Perez, Jordan S. Orange, Francisco Bonilla, Javier Chinen, Ivan K. Chinn, Morna Dorsey, Yehia El-Gamal, Terry O. Harville, Elham Hossny, Bruce Mazer, Robert Nelson, Elizabeth Secord, Stanley C. Jordan, E. Richard Stiehm, Ashley A. Vo & Mark Ballow. (2017) Update on the use of immunoglobulin in human disease: A review of evidence. Journal of Allergy and Clinical Immunology 139:3, pages S1-S46.
Crossref
Crossref
Gil Amarilyo, Simon Tarp, Ivan Foeldvari, Neta Cohen, Tracy D. Pope, Jennifer M.P. Woo, Robin Christensen & Daniel E. Furst. (2016) Biological agents in polyarticular juvenile idiopathic arthritis: A meta-analysis of randomized withdrawal trials. Seminars in Arthritis and Rheumatism 46:3, pages 312-318.
Crossref
Crossref
Nadia J. Luca, Heather F. Burnett, Wendy J. Ungar, Myla E. Moretti, Timothy Beukelman, Brian M. Feldman, Gwen Schwartz & Ahmed M. Bayoumi. (2016) Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Polyarticular Juvenile Idiopathic Arthritis. Arthritis Care & Research 68:12, pages 1803-1811.
Crossref
Crossref
Ezgi Deniz Batu, Fatma Cale Ergen, Bora Gulhan, Rezan Topaloglu, Ustun Aydingoz & Seza Ozen. (2016) Traitement par ?tanercept de cinq cas d?ost?omy?lite multifocale chronique r?currente (OMCR) r?fractaires. Revue du Rhumatisme 83:5, pages 399-401.
Crossref
Crossref
Lianne Kearsley-Fleet, Rebecca Davies, Eileen Baildam, Michael W. Beresford, Helen E. Foster, Taunton R. Southwood, Wendy Thomson & Kimme L. Hyrich. (2016) Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers. Rheumatology 55:9, pages 1556-1565.
Crossref
Crossref
Evert Hendrik Pieter van Dijkhuizen, Maja Bulatović Ćalasan, Saskia MF Pluijm, Maurits CFJ de Rotte, Sebastiaan J Vastert, Sylvia Kamphuis, Robert de Jonge & Nico M Wulffraat. (2015) Prediction of Methotrexate Intolerance in Juvenile Idiopathic Arthritis: a prospective, observational cohort study. Pediatric Rheumatology 13:1.
Crossref
Crossref
Ezgi Deniz Batu, Fatma Bilge Ergen, Bora Gulhan, Rezan Topaloglu, Ustun Aydingoz & Seza Ozen. (2015) Etanercept treatment in five cases of refractory chronic recurrent multifocal osteomyelitis (CRMO). Joint Bone Spine 82:6, pages 471-473.
Crossref
Crossref
Charles H. Spencer & Anjali Patwardhan. (2015) Pediatric Rheumatology for the Primary Care Clinicians-Recognizing Patterns of Disease. Current Problems in Pediatric and Adolescent Health Care 45:7, pages 185-206.
Crossref
Crossref
Eve M. D. Smith, Helen E. Foster & Michael W. Beresford. (2015) The development and assessment of biological treatments for children. British Journal of Clinical Pharmacology 79:3, pages 379-394.
Crossref
Crossref
Betul Sozeri, Serhan Sevgi & Ozgur Kasapcopur. (2015) Canakinumab: new treatment choice for systemic juvenile idiopathic arthritis. International Journal of Clinical Rheumatology 10:1, pages 13-19.
Crossref
Crossref
Tuba Tülay Koca & Aydın Arslan. (2015) Current Approach to Treatment of Juvenile Idiopathic Arthritis: Case Report of Hiperimmunglobulin E Syndrome Developed Juvenile Idiopathic Arthritis. Open Journal of Rheumatology and Autoimmune Diseases 05:03, pages 62-67.
Crossref
Crossref
EH Pieter van Dijkhuizen & Nico M Wulffraat. (2014) Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review. Pediatric Rheumatology 12:1.
Crossref
Crossref
Mohamed Albarouni, Ingrid Becker & Gerd Horneff. (2014) Predictors of response to methotrexate in juvenile idiopathic arthritis. Pediatric Rheumatology 12:1.
Crossref
Crossref
Mileka Gilbert & Marilynn Punaro. (2014) Blood gene expression profiling in pediatric systemic lupus erythematosus and systemic juvenile idiopathic arthritis: from bench to bedside. Pediatric Rheumatology 12:1.
Crossref
Crossref
Heinrike Schmeling, Gerd Horneff, Susanne M. Benseler & Marvin J. Fritzler. (2014) Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?. Nature Reviews Rheumatology 10:11, pages 682-690.
Crossref
Crossref
Ethan S Sen & A V Ramanan. (2014) Republished: New age of biological therapies in paediatric rheumatology. Postgraduate Medical Journal 90:1068, pages 590-596.
Crossref
Crossref
E. S. Sen & A. V. Ramanan. (2014) New age of biological therapies in paediatric rheumatology. Archives of Disease in Childhood 99:7, pages 679-685.
Crossref
Crossref
Stephanie McCarty & William Frishman. (2014) Interleukin 1β. Cardiology in Review 22:4, pages 176-181.
Crossref
Crossref
Shumpei Yokota, Tomoyuki Imagawa, Masaaki Mori, Takako Miyamae, Syuji Takei, Naomi Iwata, Hiroaki Umebayashi, Takuji Murata, Mari Miyoshi, Minako Tomiita, Norihiro Nishimoto & Tadamitsu Kishimoto. (2014) Longterm Safety and Effectiveness of the Anti-interleukin 6 Receptor Monoclonal Antibody Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan. The Journal of Rheumatology 41:4, pages 759-767.
Crossref
Crossref
Tom Vanden Berghe, Dieter Demon, Pieter Bogaert, Benjamin Vandendriessche, Alain Goethals, Bart Depuydt, Marnik Vuylsteke, Ria Roelandt, Elien Van Wonterghem, Jill Vandenbroecke, Sze Men Choi, Evelyn Meyer, Stefan Krautwald, Wim Declercq, Nozomi Takahashi, Anje Cauwels & Peter Vandenabeele. (2014) Simultaneous Targeting of IL-1 and IL-18 Is Required for Protection against Inflammatory and Septic Shock. American Journal of Respiratory and Critical Care Medicine 189:3, pages 282-291.
Crossref
Crossref
Andrea Saggini, Sergio Chimenti & Andrea Chiricozzi. (2014) IL-6 as a Druggable Target in Psoriasis: Focus on Pustular Variants. Journal of Immunology Research 2014, pages 1-10.
Crossref
Crossref
Dragos Andrei Chiran, Michael Weber, Laura Marinela Ailioaie, Eovelina Moraru, Constantin Ailioaie, Daniela Litscher & Gerhard Litscher. (2014) Intravenous Laser Blood Irradiation and Tocilizumab in a Patient with Juvenile Arthritis. Case Reports in Medicine 2014, pages 1-6.
Crossref
Crossref
FEMKE H.M. PRINCE & DANIEL H. SOLOMON. (2013) Dosing of Biologics in Juvenile Idiopathic Arthritis: Is the Sky the Limit?. The Journal of Rheumatology 40:10, pages 1643-1645.
Crossref
Crossref
Preema J. Mehta, Janet L. Alexander & H. Nida Sen. (2013) Pediatric uveitis. Current Opinion in Ophthalmology 24:5, pages 453-462.
Crossref
Crossref
Dragos Andrei Chiran, Gerhard Litscher, Michael Weber, Laura Marinela Ailioaie, Constantin Ailioaie & Daniela Litscher. (2013) Intravenous Laser Blood Irradiation Increases Efficacy of Etanercept in Selected Subtypes of Juvenile Idiopathic Arthritis: An Innovative Clinical Research Approach. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-9.
Crossref
Crossref